The primary purpose of this study is to evaluate the safety of deep brain stimulation of a brain structure called the fornix (DBS-f) in people with mild Alzheimer's disease. All device- and/or therapy-related adverse events will be assessed.
|Min Age||Max Age||Gender||Healthy Volunteers|
The primary purpose of this study is to evaluate the safety of DBS-f in people with mild Alzheimer's disease. All device- and/or therapy-related adverse events will be assessed. The secondary objective is to preliminarily estimate the treatment effect size on the outcomes of interest after 12 months. For more information about this study, visit www.advancestudy4ad.com.
|Map Marker||City||State||Zip Code||Status||Primary Contact|
Geolocation is 33.4636012, -112.0535987
Banner Alzheimer's Institute
Geolocation is 29.647247, -82.4156829
University of Florida at Gainesville
Geolocation is 39.2713976, -76.5603828
Johns Hopkins Bayview Medical Center
Geolocation is 39.9583587, -75.1953934
Hospital of the University of Pennsylvania: Penn Memory Clinic
Geolocation is 43.6534023, -79.4053266
Toronto Western Hospital
Functional Neuromodulation Ltd.
Andres Lozano, MD, PhD
University Health Network, Toronto
Constantine G. Lyketsos, MD
Johns Hopkins University